A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer
CURRENT MEDICAL RESEARCH AND OPINION, cilt.33, sa.9, ss.1559-1569, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 33 Sayı: 9
- Basım Tarihi: 2017
- Doi Numarası: 10.1080/03007995.2017.1348344
- Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1559-1569
- Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet
Özet
Background: Resistance to endocrine treatment generally occurs over time, especially in the metastatic stage. In this paper, we aimed to review the mechanisms of cyclin-dependent kinase (CDK) 4/6 inhibition and clinical usage of new agents in the light of recent literature updates.